Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 2
1991 1
1994 2
1996 1
1999 1
2018 1
2021 1
2022 1
2023 1
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.
Pérez-Amill L, Armand-Ugón M, Val-Casals M, Martín-Herreros B, Álamo JR, Peña S, Frigola G, Altuna A, Santos C, Guijarro F, Minguela A, Bataller À, Casanovas-Albertí B, Uribe-Herranz M, Navarro I, Guerreiro M, Sánchez-Martínez D, Tirado N, Velasco-Hernandez T, Menéndez P, Martínez A, Rovira M, Colomer D, González-Navarro EA, Esteve J, Urbano-Ispizua Á, Montesinos P, Delgado J, Juan M, Klein-González N. Pérez-Amill L, et al. Among authors: alamo jr. Leukemia. 2025 Oct;39(10):2432-2441. doi: 10.1038/s41375-025-02705-4. Epub 2025 Aug 6. Leukemia. 2025. PMID: 40770072
The genomic landscape of transformed splenic diffuse red pulp small B-cell lymphoma.
Grau M, Pol M, Montaner A, Mozas P, Nadeu F, Márquez-López I, Álamo JR, Navarro A, Martinez D, Frigola G, Balagué O, Lopez-Guerra M, Colomer D, Ruiz-Gaspà S, Bashiri M, Correa J, Giné E, López-Guillermo A, Campo E, López C, Matutes E, Beà S. Grau M, et al. Among authors: alamo jr. EJHaem. 2024 Oct 4;5(5):1014-1020. doi: 10.1002/jha2.1018. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415899 Free PMC article.
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.
Zugasti I, Lopez-Guerra M, Castaño-Díez S, Esteban D, Avendaño A, Pomares H, Perez A, García-Ávila S, Conejo IP, de la Fuente Montes C, Martínez-Roca A, Merchán B, Jiménez-Vicente C, Guijarro F, Álamo JR, Cortes-Bullich A, Torrecillas V, Mont L, Carcelero E, Riu G, Zamora L, Bargay J, Triguero A, Suarez-Lledó M, Salas MQ, López-Cadenas F, Ramos F, Xicoy B, Valcárcel D, Arnan M, Martínez C, Rovira M, Fernández-Avilés F, Díez-Campelo M, Esteve J, Díaz-Beyá M. Zugasti I, et al. Among authors: alamo jr. Exp Hematol Oncol. 2025 Apr 26;14(1):61. doi: 10.1186/s40164-025-00652-5. Exp Hematol Oncol. 2025. PMID: 40287746 Free PMC article.
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.
Álamo JR, Torres LM, Castaño-Díez S, Mensa-Vilaró A, Mónica López-Guerra M, Zugasti I, Díaz J, Jiménez-Vicente C, Plaza S, Fabregat V, de Landazuri IO, Yagüe J, Espinosa G, Sanmartí R, Rozman M, Guijarro F, Cortes A, Triguero A, Cardús A, Cuartas A, Cornejo M, Esteve J, Aróstegui JI, Díaz-Beyá M. Álamo JR, et al. Br J Haematol. 2025 Feb;206(2):565-575. doi: 10.1111/bjh.19953. Epub 2025 Jan 13. Br J Haematol. 2025. PMID: 39806534
Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
Ribera-Cortada I, Guerrero-Pineda J, Trias I, Veloza L, Garcia A, Marimon L, Diaz-Mercedes S, Alamo JR, Rodrigo-Calvo MT, Vega N, López Del Campo R, Parra-Medina R, Ajami T, Martínez A, Reig O, Ribal MJ, Corral-Molina JM, Jares P, Ordi J, Rakislova N. Ribera-Cortada I, et al. Among authors: alamo jr. Int J Mol Sci. 2021 Dec 27;23(1):251. doi: 10.3390/ijms23010251. Int J Mol Sci. 2021. PMID: 35008677 Free PMC article.
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Castaño-Díez S, Álamo JR, López-Guerra M, Gómez-Hernando M, Zugasti I, Jiménez-Vicente C, Guijarro F, López-Oreja I, Esteban D, Charry P, Torrecillas V, Mont-de Torres L, Cortés-Bullich A, Bataller Á, Guardia A, Munárriz D, Carcelero E, Riu G, Triguero A, Tovar N, Vela D, Beà S, Costa D, Colomer D, Rozman M, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: alamo jr. Oncologist. 2025 Feb 6;30(2):oyae246. doi: 10.1093/oncolo/oyae246. Oncologist. 2025. PMID: 39349391 Free PMC article. Review.
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
Castaño-Díez S, López-Guerra M, Bosch-Castañeda C, Bataller A, Charry P, Esteban D, Guijarro F, Jiménez-Vicente C, Castillo-Girón C, Cortes A, Martínez-Roca A, Triguero A, Álamo JR, Beà S, Costa D, Colomer D, Rozman M, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: alamo jr. Cancers (Basel). 2022 Aug 25;14(17):4107. doi: 10.3390/cancers14174107. Cancers (Basel). 2022. PMID: 36077644 Free PMC article.
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
Guijarro F, Castaño-Díez S, Jiménez-Vicente C, Garrote M, Álamo JR, Gómez-Hernando M, López-Oreja I, Morata J, López-Guerra M, López C, Beà S, Costa D, Colomer D, Díaz-Beyá M, Rozman M, Esteve J. Guijarro F, et al. Among authors: alamo jr. Int J Mol Sci. 2024 Aug 8;25(16):8669. doi: 10.3390/ijms25168669. Int J Mol Sci. 2024. PMID: 39201354 Free PMC article.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Castaño-Díez S, Pomares H, Esteban D, Guijarro F, Jiménez-Vicente C, Zugasti I, Álamo JR, Mayayo VT, López-Guerra M, de la Fuente C, Charry P, Cortés-Bullich A, Bataller Á, Maluquer C, Colomer D, Rozman M, Arnan M, Xicoy B, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: alamo jr. Br J Haematol. 2024 Mar;204(3):892-897. doi: 10.1111/bjh.19217. Epub 2023 Nov 27. Br J Haematol. 2024. PMID: 38013238
Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes.
Guijarro F, Cabezas S, Dabad M, Bataller A, López C, Castaño-Díez S, Jiménez-Vicente C, Cortés-Bullich A, Garrote M, Álamo JR, Prieto M, Cardús A, Pratcorona M, Rozman M, Aymerich M, Villamor N, Colomer D, Morata J, Esteve-Codina A, Beà S, Costa D, Díaz-Beyá M, López-Guerra M, Esteve J. Guijarro F, et al. Among authors: alamo jr. Blood Neoplasia. 2025 Jan 16;2(2):100068. doi: 10.1016/j.bneo.2025.100068. eCollection 2025 May. Blood Neoplasia. 2025. PMID: 40453146 Free PMC article.
20 results